Fractional proliferation: A method to deconvolve cell population dynamics from single-cell data

Nature Methods

Volumn 9, Issue 9, 2012, Pages 923-928

  Tyson, Darren R ^a   Garbett, Shawn P ^a   Frick, Peter L ^a   Quaranta, Vito ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; CANCER CELL; CELL COUNT; CELL CYCLE ARREST; CELL DEATH; CELL DIVISION; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; PRIORITY JOURNAL; QUIESCENCE;

CARCINOMA, SQUAMOUS CELL; CELL COUNT; CELL PROLIFERATION; HUMANS; LUNG NEOPLASMS; MICROSCOPY, VIDEO; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; SINGLE-CELL ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 84866139606     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.2138     Document Type: Article

References (32)

1. Hughes, M. et al. Early drug discovery and development guidelines: for academic researchers, collaborators, and start-up companies. in Assay Guidance Manual (eds. Sittampalam, G.S. et al.) (Eli Lilly & Co. and the National Center for Advancing Translational Sciences, 2004).
2. Terry, N.H. & White, R.A. Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo. Nat. Protoc. 1, 859-869 (2006).
3. van Genderen, H. et al. In vitro measurement of cell death with the annexin A5 affnity assay. Nat. Protoc. 1, 363-367 (2006).
4. Hawkins, E.D. et al. Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. Nat. Protoc. 2, 2057-2067 (2007).
5. Sakaue-Sawano, A. et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132, 487-498 (2008).
6. d'Onofrio, A., Fasano, A. & Monechi, B. A generalization of Gompertz law compatible with the Gyllenberg-Webb theory for tumour growth. Math. Biosci. 230, 45-54 (2011).
7. Gyllenberg, M. & Webb, G.F. Age-size structure in populations with quiescence. Math. Biosci. 86, 67-95 (1987).
8. Florian, J.A. Jr., Eiseman, J.L. & Parker, R.S. Accounting for quiescent cells in tumour growth and cancer treatment. Syst. Biol. (Stevenage) 152, 185-192 (2005).
9. Kozusko, F. & Bajzer, Z. Combining Gompertzian growth and cell population dynamics. Math. Biosci. 185, 153-167 (2003).
10. Turner, M.E. Jr., Bradley, E.L. Jr., Kirk, K.A. & Pruitt, K.M. A theory of growth. Math. Biosci. 29, 367-373 (1976).
11. Grushka, E. Characterization of exponentially modifed Gaussian peaks in chromatography. Anal. Chem. 44, 1733-1738 (1972).
12. Powell, E.O. Growth rate and generation time of bacteria, with special reference to continuous culture. J. Gen. Microbiol. 15, 492-511 (1956).
13. McLachlan, G.J. & Peel, D. Finite Mixture Models (Wiley, 2000).
14. Weinstein, I.B. & Joe, A.K. Mechanisms of disease: oncogene addiction\a rationale for molecular targeting in cancer therapy. Nat. Clin. Pract. Oncol. 3, 448-457 (2006).
15. Gong, Y. et al. Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas. PLoS Med. 4, e294 (2007).
16. Sharma, S.V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69-80 (2010).
17. Harder, N. et al. Automatic analysis of dividing cells in live cell movies to detect mitotic delays and correlate phenotypes in time. Genome Res. 19, 2113-2124 (2009).
18. Held, M. et al. CellCognition: time-resolved phenotype annotation in high-throughput live cell imaging. Nat. Methods 7, 747-754 (2010).
19. Sigoillot, F.D. et al. A time-series method for automated measurement of changes in mitotic and interphase duration from time-lapse movies. PLoS ONE 6, e25511 (2011).
20. Bos, M. et al. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin. Cancer Res. 3, 2099-2106 (1997).
21. Ciardiello, F. & Tortora, G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin. Cancer Res. 7, 2958-2970 (2001).
22. Ling, Y.H. et al. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines. Mol. Pharmacol. 72, 248-258 (2007).
23. Grünwald, V. & Hidalgo, M. Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J. Natl. Cancer Inst. 95, 851-867 (2003).
24. Pao, W. & Chmielecki, J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat. Rev. Cancer 10, 760-774 (2010).
25. Riely, G.J. et al. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with geftinib or erlotinib. Clin. Cancer Res. 12, 839-844 (2006).
26. Golubev, A. Exponentially modifed Gaussian (EMG) relevance to distributions related to cell proliferation and differentiation. J. Theor. Biol. 262, 257-266 (2010).
27. Sbano, L. & Kirkilionis, M. Multiscale analysis of reaction networks. Theory Biosci. 127, 107-123 (2008).
28. Chichagov, V.V. Asymptotic behavior of the frst arrival time in Markovian random walks. J. Math. Sci. 39, 2944-2948 (1987).
29. Abràmoff, M.D., Magalhães, P.J. & Ram, S.J. Image processing with ImageJ. Biophotonics Int. 11, 36-42 (2004).
30. Rasband, W.S. ImageJ v.1.45p (US National Institutes of Health, Bethesda, Maryland, 1997-2012).
31. R Development Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2010).
32. Quaranta, V. et al. Trait variability of cancer cells quantifed by high-content automated microscopy of single cells. Methods Enzymol. 467, 23-57 (2009).